Viatris Inc Stock Ownership - Who owns Viatris?

Open Broker Account

Insider buying vs selling

Have Viatris Inc insiders been buying or selling?
Der Meer Mohr Pauline VanDirector2022-08-179,440$10.58
Menassie TaddesePresident Emerging Markets2022-05-278,813$12.07
Michael GoettlerChief Executive Officer2022-03-21280$10.39
Menassie TaddesePresident Emerging Markets2022-03-2134$10.39
Der Meer Mohr Pauline VanDirector2022-03-213$10.39
W. Don CornwellDirector2022-03-152,700$9.90
Michael GoettlerChief Executive Officer2022-03-1550,352$9.87
Robert J. CouryExecutive Chairman2022-03-11250,000$10.07
Robert J. CouryExecutive Chairman2022-03-09250,000$10.28
Paul CampbellChief Accounting Officer and Corporate Controller2022-03-028$10.48

1 of 6

VTRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTRS insiders and whales buy or sell their stock.

VTRS Shareholders

What type of owners hold Viatris Inc stock?
Vanguard Group Inc11.99%145,344,236$1.26BInstitution
Laboratories Abbott11.20%135,750,000$1.18BInsider
Blackrock Inc7.71%93,510,570$812.61MInstitution
Products Abbott5.18%62,782,018$545.58MInsider
State Street Corp4.79%58,084,474$504.75MInstitution
Davis Selected Advisers4.57%55,466,147$482.00MInstitution
Wellington Management Group LLP4.56%55,233,099$479.98MInstitution
Geode Capital Management LLC2.05%24,881,035$216.22MInstitution
Camber Capital Management LP1.90%23,000,000$199.87MInstitution
Deerfield Management Company LP Series C1.70%20,673,700$179.65MInstitution

1 of 3

VTRS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTRS73.13%17.41%Net SellingNet Selling
TEVA45.58%0.74%Net SellingNet Selling
CTLT79.85%20.15%Net BuyingNet Selling
ELAN90.56%9.44%Net SellingNet Buying

Viatris Stock Ownership FAQ

Who owns Viatris?

Viatris (NASDAQ: VTRS) is owned by 73.13% institutional shareholders, 17.41% Viatris insiders, and 9.47% retail investors. Laboratories Abbott is the largest individual Viatris shareholder, owning 135.75M shares representing 11.20% of the company. Laboratories Abbott's Viatris shares are currently valued at $1.16B.

If you're new to stock investing, here's how to buy Viatris stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.